9th Clinical Biomarkers & World CDx Boston 2018 summit

2 October - 5 October, 2018

info@world-cdx.com

+1 415 735 3289

http://world-cdx.com/

The Renaissance Boston Waterfront, USA

Organized By:

Hanson Wade

+44 (0)203 141 8700

info@hansonwade.com

https://hansonwade.com/

52 Grosvenor Gardens, London, SW1W 0AU

About 9th Clinical Biomarkers & World CDx Boston 2018 summit

Enhance the Translation & Clinical Validation of Novel Predictive Biomarkers & Maximize the Commercialization of Diagnostic-Enabled Precision Medicines

The 9th Clinical Biomarkers & World CDx Boston 2018 summit is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.

As the place to be for the precision medicine field, Clinical Biomarkers & World CDx Boston covers end-to-end the development, clinical implementation and commercialisation of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from R&D to providing patients with the right treatment decision and most effective therapies at the right time.

Speakers

Speaker

More...

Exhibitors Profile

Companion Diagnostics

Key topics to be addressed in 2018:

Building a commercial strategy to achieve a global footprint for precision medicine and its associated test
Overcoming hurdles in reimbursement for diagnostic enabled therapeutics to improve adoption and uptake in healthcare
Accelerating the demonstration of clinical utility and regulatory success for diagnostic-enabled precision medicines
Improving drug-IVD co-development to streamline the clinical development, approval and launch of a drug-Dx product

Clinical Biomarkers

Key topics to be addressed in 2018:

Advancing clinical validation of patient stratifying predictive biomarkers to robustly define selection approaches
Overcoming disparity in validation and standardization of assays to improve precision medicine development and adoption
Building the best biomarker driven precision medicine clinical trials to fast-track candidate efficacy demonstration and approval
Accelerating the translational development of predictive signatures to improve and streamline exploratory biomarker strategies

Event Partners

More...